Literature DB >> 22593611

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.

Montserrat Cols1, Carolina M Barra, Bing He, Irene Puga, Weifeng Xu, April Chiu, Wayne Tam, Daniel M Knowles, Stacey R Dillon, John P Leonard, Richard R Furman, Kang Chen, Andrea Cerutti.   

Abstract

Chronic lymphocytic leukemia (CLL) is a clonal B cell disorder of unknown origin. Accessory signals from the microenvironment are critical for the survival, expansion, and progression of malignant B cells. We found that the CLL stroma included microvascular endothelial cells (MVECs) expressing BAFF and APRIL, two TNF family members related to the T cell-associated B cell-stimulating molecule CD40L. Constitutive release of soluble BAFF and APRIL increased upon engagement of CD40 on MVECs by CD40L aberrantly expressed on CLL cells. In addition to enhancing MVEC expression of CD40, leukemic CD40L induced cleavases that elicited intracellular processing of pro-BAFF and pro-APRIL proteins in MVECs. The resulting soluble BAFF and APRIL proteins delivered survival, activation, Ig gene remodeling, and differentiation signals by stimulating CLL cells through TACI, BAFF-R, and BCMA receptors. BAFF and APRIL further amplified CLL cell survival by upregulating the expression of leukemic CD40L. Inhibition of TACI, BCMA, and BAFF-R expression on CLL cells; abrogation of CD40 expression in MVECs; or suppression of BAFF and APRIL cleavases in MVECs reduced the survival and diversification of malignant B cells. These data indicate that BAFF, APRIL, and CD40L form a CLL-enhancing bidirectional signaling network linking neoplastic B cells with the microvascular stroma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593611      PMCID: PMC3370079          DOI: 10.4049/jimmunol.1102066

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses.

Authors:  Claudia Bossen; Aubry Tardivel; Laure Willen; Carrie A Fletcher; Mai Perroud; Friedrich Beermann; Antonius G Rolink; Martin L Scott; Fabienne Mackay; Pascal Schneider
Journal:  Eur J Immunol       Date:  2011-02-01       Impact factor: 5.532

2.  Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies.

Authors:  Stephen A Mihalcik; Renee C Tschumper; Diane F Jelinek
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

3.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

4.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Authors:  B D Cheson; J M Bennett; M Grever; N Kay; M J Keating; S O'Brien; K R Rai
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

Review 5.  Innate control of B cell responses.

Authors:  Andrea Cerutti; Irene Puga; Montserrat Cols
Journal:  Trends Immunol       Date:  2011-03-16       Impact factor: 16.687

Review 6.  Immunoglobulin responses at the mucosal interface.

Authors:  Andrea Cerutti; Kang Chen; Alejo Chorny
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

7.  The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

Authors:  Yair Herishanu; Patricia Pérez-Galán; Delong Liu; Angélique Biancotto; Stefania Pittaluga; Berengere Vire; Federica Gibellini; Ndegwa Njuguna; Elinor Lee; Lawrence Stennett; Nalini Raghavachari; Poching Liu; J Philip McCoy; Mark Raffeld; Maryalice Stetler-Stevenson; Constance Yuan; Richard Sherry; Diane C Arthur; Irina Maric; Therese White; Gerald E Marti; Peter Munson; Wyndham H Wilson; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

8.  Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.

Authors:  Anne J Novak; Deanna M Grote; Mary Stenson; Steven C Ziesmer; Thomas E Witzig; Thomas M Habermann; Brandon Harder; Kay M Ristow; Richard J Bram; Diane F Jelinek; Jane A Gross; Stephen M Ansell
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

9.  VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.

Authors:  Yean K Lee; Nancy D Bone; Ann K Strege; Tait D Shanafelt; Diane F Jelinek; Neil E Kay
Journal:  Blood       Date:  2004-03-02       Impact factor: 22.113

10.  B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.

Authors:  Irene Puga; Montserrat Cols; Carolina M Barra; Bing He; Linda Cassis; Maurizio Gentile; Laura Comerma; Alejo Chorny; Meimei Shan; Weifeng Xu; Giuliana Magri; Daniel M Knowles; Wayne Tam; April Chiu; James B Bussel; Sergi Serrano; José Antonio Lorente; Beatriz Bellosillo; Josep Lloreta; Nuria Juanpere; Francesc Alameda; Teresa Baró; Cristina Díaz de Heredia; Núria Torán; Albert Català; Montserrat Torrebadell; Claudia Fortuny; Victoria Cusí; Carmen Carreras; George A Diaz; J Magarian Blander; Claire-Michèle Farber; Guido Silvestri; Charlotte Cunningham-Rundles; Michaela Calvillo; Carlo Dufour; Lucia Dora Notarangelo; Vassilios Lougaris; Alessandro Plebani; Jean-Laurent Casanova; Stephanie C Ganal; Andreas Diefenbach; Juan Ignacio Aróstegui; Manel Juan; Jordi Yagüe; Nizar Mahlaoui; Jean Donadieu; Kang Chen; Andrea Cerutti
Journal:  Nat Immunol       Date:  2011-12-25       Impact factor: 25.606

View more
  36 in total

1.  Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia.

Authors:  Barbara L Andersen; Neha Godiwala Goyal; David M Weiss; Travis D Westbrook; Kami J Maddocks; John C Byrd; Amy J Johnson
Journal:  Cancer       Date:  2018-05-14       Impact factor: 6.860

Review 2.  Regulatory roles of the tumor necrosis factor receptor BCMA.

Authors:  Christine M Coquery; Loren D Erickson
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

3.  FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.

Authors:  Preetesh Jain; Hun Ju Lee; Wei Qiao; William Wierda; Ohad Benjamini; Jan Burger; Alessandra Ferrajoli; Zeev Estrov; Hagop Kantarjian; Michael Keating; Susan O'Brien
Journal:  Cancer       Date:  2014-07-15       Impact factor: 6.860

4.  Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.

Authors:  Emily M McWilliams; Christopher R Lucas; Timothy Chen; Bonnie K Harrington; Ronni Wasmuth; Amanda Campbell; Kerry A Rogers; Carolyn M Cheney; Xiaokui Mo; Leslie A Andritsos; Farrukh T Awan; Jennifer Woyach; William E Carson; Jonathan Butchar; Susheela Tridandapani; Erin Hertlein; Carlos E Castro; Natarajan Muthusamy; John C Byrd
Journal:  Blood Adv       Date:  2019-02-12

Review 5.  Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.

Authors:  Noelia Purroy; Catherine J Wu
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

6.  Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.

Authors:  Jerome Paggetti; Franziska Haderk; Martina Seiffert; Bassam Janji; Ute Distler; Wim Ammerlaan; Yeoun Jin Kim; Julien Adam; Peter Lichter; Eric Solary; Guy Berchem; Etienne Moussay
Journal:  Blood       Date:  2015-06-22       Impact factor: 22.113

7.  RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.

Authors:  Jingjing Xu; Peng Zhou; Wenjuan Wang; Aining Sun; Feng Guo
Journal:  J Mol Med (Berl)       Date:  2013-09-17       Impact factor: 4.599

8.  Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.

Authors:  Amit K Mittal; Nagendra K Chaturvedi; Karan J Rai; Christine E Gilling-Cutucache; Tara M Nordgren; Margaret Moragues; Runqing Lu; Rene Opavsky; Greg R Bociek; Dennis D Weisenburger; Javeed Iqbal; Shantaram S Joshi
Journal:  Mol Med       Date:  2014-07-15       Impact factor: 6.354

9.  Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.

Authors:  Ying-Xin Xie; Li-Yu He; Xian Chen; Xiao-Fei Peng; Mu-Yao Ye; Yu-Jing Zhao; Wen-Zhe Yan; Chan Liu; Jing Shao; You-Ming Peng
Journal:  Int Urol Nephrol       Date:  2016-07-27       Impact factor: 2.370

Review 10.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.